Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 12/2016

Open Access 01-12-2016 | Original Article

Randomized controlled trial of supportive-expressive group therapy and body-mind-spirit intervention for Chinese non-metastatic breast cancer patients

Authors: Rainbow T. H. Ho, Ted C. T. Fong, Phyllis H. Y. Lo, Samuel M. Y. Ho, Peter W. H. Lee, Pamela P. Y. Leung, David Spiegel, Cecilia L. W. Chan

Published in: Supportive Care in Cancer | Issue 12/2016

Login to get access

Abstract

Purpose

This study aimed to evaluate the efficacy of supportive-expressive group (SEG) therapy and body-mind-spirit (BMS) intervention on emotional suppression and psychological distress in Chinese breast cancer patients.

Methods

This three-arm randomized controlled trial assigned 157 non-metastatic breast cancer patients to BMS, SEG, or social support control group. SEG focused on emotional expression and group support, whereas BMS emphasized relaxation and self-care. All groups received 2-h weekly sessions for 8 weeks. The participants completed measurements on emotional suppression, perceived stress, anxiety, and depression at baseline and three follow-up assessments in 1 year.

Results

Using latent growth modeling, overall group difference was found for emotional suppression (χ 2(2) = 8.88, p = 0.012), marginally for perceived stress (χ 2(2) = 5.70, p = 0.058), but not for anxiety and depression (χ 2(2) = 0.19–0.94, p > 0.05). Post-hoc analyses revealed a significant and moderate reduction (Cohen d = 0.55, p = 0.007) in emotional suppression in SEG compared to control group, whereas BMS resulted in a marginally significant and moderate fall (d = 0.46, p = 0.024) in perceived stress. Neither SEG nor BMS significantly improved anxiety and depression (d < 0.20, p > 0.05).

Conclusions

The present results did not demonstrate overall effectiveness for either BMS or SEG therapy in the present sample of Chinese non-metastatic breast cancer patients. The participants appear to derive only modest benefits in terms of their psychological well-being from either intervention.
Literature
1.
Ho RTH, Fong TCT, Cheung IKM (2014) Cancer-related fatigue in breast cancer patients: factor mixture models with continuous non-normal distributions. Qual Life Res 23:2909–2916CrossRefPubMed
2.
3.
Mosher CE, DuHamel KN (2012) An examination of distress, sleep, and fatigue in metastatic breast cancer patients. Psychooncology 21:100–107CrossRefPubMed
4.
Lam WWT, Shing YT, Bonanno GA, Mancini AD, Fielding R (2012) Distress trajectories at the first year diagnosis of breast cancer in relation to 6 years survivorship. Psychooncology 21:90–99CrossRefPubMed
5.
Watson M, Greer S, Rowden L, Gorman C, Robertson B, Bliss JM, Tunmore R (1991) Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients. Psychol Med 21:51–57CrossRefPubMed
6.
Schlatter MC, Cameron LD (2010) Emotional suppression tendencies as predictors of symptoms, mood, and coping appraisals during AC chemotherapy for breast cancer treatment. Ann Behav Med 40:15–29CrossRefPubMed
7.
Iwamitsu Y, Shimoda K, Abe H, Tani T, Okawa M, Buck R (2005) The relation between negative emotional suppression and emotional distress in breast cancer diagnosis and treatment. Health Commun 18:201–215CrossRefPubMed
8.
Spiegel D, Classen C (2000) Group therapy for cancer patients: a research based handbook of psychosocial care. Basic Books, New York
9.
Giese-Davis J, Koopman C, Butler LD, Classen C, Cordova M, Fobair P, Benson J, Kraemer HC, Spiegel D (2002) Change in emotion-regulation strategy for women with metastatic breast cancer following supportive-expressive group therapy. J Consult Clin Psychol 70:916–925CrossRefPubMed
10.
Butler LD, Koopman C, Neri E, Giese-Davis J, Palesh O, Thorne-Yocam KA, Dimiceli S, Chen X-H, Fobair P, Kraemer HC (2009) Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer. Health Psychol 28:579CrossRefPubMed
11.
Goodwin PJ, Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, Drysdale E, Hundleby M, Chochinov HM, Navarro M, Speca M, Hunter J (2001) The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719–1726CrossRefPubMed
12.
Kissane DW, Grabsch B, Clarke DM, Christie G, Clifton D, Gold S, Hill C, Morgan A, McDermott F, Smith GC (2004) Supportive-expressive group therapy: the transformation of existential ambivalence into creative living while enhancing adherence to anti-cancer therapies. Psychooncology 13:755–768CrossRefPubMed
13.
Giese-Davis J, Collie K, Rancourt KMS, Neri E, Kraemer HC, Spiegel D (2011) Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 29:413–420CrossRefPubMed
14.
Reuter K, Scholl I, Sillem M, Hasenburg A, Harter M (2010) Implementation and benefits of psychooncological group interventions in German breast centers: a pilot study on supportive-expressive group therapy for women with primary breast cancer. Breast Care 5:91–96CrossRefPubMedPubMedCentral
15.
Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, Speca M (2013) Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer (MINDSET). J Clin Oncol 31:3119-3126CrossRefPubMed
16.
Vos PJ, Garssen B, Visser AP, Duivenvoorden HJ, de Haes HC (2004) Psychosocial intervention for women with primary, non-metastatic breast cancer: a comparison between participants and non-participants. Psychother Psychosom 73:276–285CrossRefPubMed
17.
Vos PJ, Visser AP, Garssen B, Duivenvoorden HJ, Haes HC (2007) Effectiveness of group psychotherapy compared to social support groups in patients with primary, non-metastatic breast cancer. J Psychosoc Oncol 25:37–60CrossRefPubMed
18.
Boesen EH, Karlsen R, Christensen J, Paaschburg B, Nielsen D, Bloch IS, Christiansen B, Jacobsen K, Johansen C (2011) Psychosocial group intervention for patients with primary breast cancer: a randomised trial. Eur J Cancer 47:1363–1372CrossRefPubMed
19.
Chan CLW, Ho RTH, Lee PWH, Cheng JYY, Leung PPY, Foo W, Chow LWH, Sham JST, Spiegel D (2006) A randomized controlled trial of psychosocial interventions using the psychophysiological framework for Chinese breast cancer patients. J Psychosoc Oncol 24:3–26CrossRefPubMed
20.
Ho RTH, Chan CLW, Ho SMY (2004) Emotional control in Chinese female cancer survivors. Psychooncology 13:808–817CrossRefPubMed
21.
Chan CLW, Ho PSY, Chow E (2001) A body-mind-spirit model in health: an Eastern approach. Soc Work Health Care 34:261–282CrossRefPubMed
22.
Casellas‐Grau A, Font A, Vives J (2014) Positive psychology interventions in breast cancer. A syst Rev Psycho Oncol 23:9–19CrossRef
23.
Ng SM, Fong TCT, Wang XL, Wang YJ (2012) Confirmatory factor analysis of the stagnation scale—a traditional Chinese medicine construct operationalized for mental health practice. Int J Behav Med 19:228–233CrossRefPubMed
24.
Goyal M, Singh S, Sibinga EM, Gould NF, Rowland Seymour A, Sharma R, Berger Z, Sleicher D, Maron DD, Shihab HM (2014) Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Med 174:357–368CrossRef
25.
Liu CJ, Hsiung PC, Chang KJ, Liu YF, Wang KC, Hsiao FH, Ng SM, Chan CLW (2008) A study on the efficacy of body-mind-spirit group therapy for patients with breast cancer. J Clin Nurs 17:2539–2549CrossRefPubMed
26.
Hsiao FH, Jow GM, Kuo WH, Chang KJ, Liu YF, Ho RTH, Ng SM, Chan CLW, Lai YM, Chen YT (2012) The effects of psychotherapy on psychological well-being and diurnal cortisol patterns in breast cancer survivors. Psychother Psychosom 81:173–182CrossRefPubMed
27.
Chan CLW (2001) An eastern body-mind-spirit approach: a training manual with one-second techniques. The University of Hong Kong, Hong Kong
28.
Classen CC, Diamond S, Soleman A, Fobair P, Spira J, Spiegel D (1993) Brief supportive-expressive group therapy for women with primary breast cancer: a treatment manual. In: Editor (ed)^(eds) Book Brief supportive-expressive group therapy for women with primary breast cancer: a treatment manual. Psychosocial Treatment Laboratory, Stanford, CA
29.
Leung DYP, Lam TH, Chan SSC (2010) Three versions of perceived stress scale: validation in a sample of Chinese cardiac patients who smoke. BMC Public Health 10:513CrossRefPubMedPubMedCentral
30.
Fong TCT, Ho RTH (2013) Factor analyses of the Hospital Anxiety and Depression Scale: a Bayesian structural equation modeling approach. Qual Life Res 22:2857–2863CrossRefPubMed
31.
Pan PC, Goldberg D (1990) A comparison of the validity of GHQ-12 and CHQ-12 in Chinese primary care patients in Manchester. Psychol Med 20:931–940CrossRefPubMed
32.
Muthén LK, Muthén BO (2002) How to use a Monte Carlo study to decide on sample size and determine power. Struct Equ Modeling 9:599–620CrossRef
33.
Duncan TE, Duncan SC (2004) An introduction to latent growth curve modeling. Behav Ther 35:333–363CrossRef
34.
35.
Muthén LK, Muthén B (1998) Mplus user’s guide. Muthen & Muthen, Los Angeles, CA
36.
Little RJA, Rubin DB (1987) Statistical analysis with missing data. Wiley, New York
37.
Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 6:1–55CrossRef
38.
Classen C, Butler LD, Koopman C, Miller E, DiMiceli S, Giese Davis J, Fobair P, Carlson RW, Kraemer HC, Spiegel D (2001) Supportive-expressive group therapy and distress in patients with metastatic breast cancer—a randomized clinical intervention trial. Arch Gen Psychiatry 58:494–501CrossRefPubMed
39.
Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R (2011) Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol: JCO 2040:8922
40.
Grassi L, Sabato S, Rossi E, Marmai L, Biancosino B (2010) Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: a pilot study. Psychother Psychosom 79:39–47CrossRefPubMed
41.
Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hébert JR (2012) The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat 131:99–109CrossRefPubMed
Metadata
Title
Randomized controlled trial of supportive-expressive group therapy and body-mind-spirit intervention for Chinese non-metastatic breast cancer patients
Authors
Rainbow T. H. Ho
Ted C. T. Fong
Phyllis H. Y. Lo
Samuel M. Y. Ho
Peter W. H. Lee
Pamela P. Y. Leung
David Spiegel
Cecilia L. W. Chan
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3350-8

Other articles of this Issue 12/2016

Supportive Care in Cancer 12/2016 Go to the issue

Original Article

Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient’s assessment of own functioning inventory

Original Article

Efficacy and safety of lipegfilgrastim compared with placebo in patients with non-small cell lung cancer receiving chemotherapy: post hoc analysis of elderly versus younger patients

Original Article

An audit of acute oncology services: patient experiences of admission procedures and staff utilisation of a new telephone triage system

Original Article

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement

Original Article

Supporting self-management of pain by patients with advanced cancer: views of palliative care professionals

Original Article

Post-treatment problems of African American breast cancer survivors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits